Literature DB >> 9658127

Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression.

T F Baumert1, A Marrone, J Vergalla, T J Liang.   

Abstract

Functional analysis of naturally occurring hepatitis B virus (HBV) mutations is crucial in understanding their impact on disease. We have recently identified two mutations in the HBV core promoter of an HBV strain associated with fulminant hepatitis leading to highly (15-fold) enhanced replication as a result of increased viral encapsidation of pregenomic RNA into the core particles (T. F. Baumert et al., J. Clin. Invest. 98:2268-2276, 1996). Functional studies in an encapsidation assay had demonstrated that the increase in encapsidation was largely independent of pregenomic RNA transcription. In this study, we define the molecular mechanism whereby the two core promoter mutations (C to T at nucleotide [nt] 1768 and T to A at nt 1770) result in enhanced viral encapsidation and replication. The effect of these mutations leading to increased encapsidation is mediated through enhanced core protein synthesis (15-fold) by the mutant virus. The marked increase in core protein synthesis is largely a result of posttranscriptional or translational effect of the mutations because the mutations resulted in only a twofold increase in pregenomic RNA transcription. In addition, this effect appears to be selective for core expression since reverse transcriptase-polymerase expression was increased only twofold. trans-complementation analyses of HBV replication demonstrated that enhanced replication occurred only when the mutations were provided together with the core protein in trans, confirming the functional association of the core promoter mutations and core protein expression. In addition, the effect of the mutations appears to be quantitatively dependent on the strain background to which the mutations were introduced. Our study suggests that the HBV core promoter regulates core protein expression at both transcriptional and posttranscriptional levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658127      PMCID: PMC109887     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation.

Authors:  M Sterneck; S Günther; T Santantonio; L Fischer; C E Broelsch; H Greten; H Will
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

2.  The mechanism of natural occurrence of two closely linked HBV precore predominant mutations.

Authors:  T T Yuan; A Faruqi; J W Shih; C Shih
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

Review 3.  When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.

Authors:  L E Maquat
Journal:  RNA       Date:  1995-07       Impact factor: 4.942

4.  Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication.

Authors:  V E Buckwold; Z Xu; M Chen; T S Yen; J H Ou
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E.

Authors:  D Rousseau; R Kaspar; I Rosenwald; L Gehrke; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

Review 6.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

7.  Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis.

Authors:  S Sato; K Suzuki; Y Akahane; K Akamatsu; K Akiyama; K Yunomura; F Tsuda; T Tanaka; H Okamoto; Y Miyakawa; M Mayumi
Journal:  Ann Intern Med       Date:  1995-02-15       Impact factor: 25.391

8.  Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

Authors:  M Miura; H Zhu; R Rotello; E A Hartwieg; J Yuan
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products.

Authors:  J Huang; T J Liang
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

10.  Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.

Authors:  J R Pollack; D Ganem
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  26 in total

1.  Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.

Authors:  W Yang; J Summers
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.

Authors:  Li Zong; Yanli Qin; Haodi Jia; Lei Ye; Yongxiang Wang; Jiming Zhang; Jack R Wands; Shuping Tong; Jisu Li
Journal:  Virology       Date:  2017-03-03       Impact factor: 3.616

Review 3.  Pathogenesis of hepatitis B virus infection.

Authors:  Thomas F Baumert; Robert Thimme; Fritz von Weizsäcker
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Authors:  Xiping Zhao; Zhen-Ya Tang; Bettina Klumpp; Guido Wolff-Vorbeck; Heidi Barth; Shoshana Levy; Fritz von Weizsäcker; Hubert E Blum; Thomas F Baumert
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.

Authors:  Takashi Hoshino; Hitoshi Takagi; Yuhei Suzuki; Atsushi Naganuma; Ken Sato; Satoru Kakizaki; Tsutomu Nishizawa; Hiroaki Okamoto; Masanobu Yamada
Journal:  Clin J Gastroenterol       Date:  2016-05-10

6.  Viral factors and outcome of chronic hepatitis B revisited.

Authors:  François Habersetzer; Rémy Moenne-Loccoz; Thomas F Baumert
Journal:  Hepatol Int       Date:  2013-09-11       Impact factor: 6.047

7.  A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus.

Authors:  Y Kajiya; K Hamasaki; K Nakata; S Miyazoe; Y Takeda; S Higashi; K Ohkubo; T Ichikawa; K Nakao; Y Kato; K Eguchi
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

8.  In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.

Authors:  Richard A Heipertz; Thomas G Miller; Colleen M Kelley; William E Delaney; Stephen A Locarnini; Harriet C Isom
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

9.  Prevalence of hepatitis B virus genotype D in precore mutants among chronic liver disease patients from New Delhi, India.

Authors:  Premashis Kar; Sunil K Polipalli; Saket Chattopadhyay; Zahid Hussain; Abdul Malik; Syed A Husain; Subhash Medhi; Nargis Begum
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

10.  Critical roles of nuclear receptor response elements in replication of hepatitis B virus.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.